Publicacións en colaboración con investigadores/as de University of Bologna (13)

2023

  1. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

2020

  1. European lipodystrophy registry: Background and structure

    Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1

  2. Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis

    European journal of endocrinology, Vol. 182, Núm. 1, pp. 11-21

2019

  1. Altered adipocyte differentiation and unbalanced autophagy in type 2 Familial Partial Lipodystrophy: an in vitro and in vivo study of adipose tissue browning

    Experimental and Molecular Medicine, Vol. 51, Núm. 8

  2. Rising rural body-mass index is the main driver of the global obesity epidemic in adults

    Nature

2017

  1. Pharmacological inhibition of cannabinoid receptor 1 stimulates gastric release of nesfatin-1 via the mTOR pathway

    World Journal of Gastroenterology, Vol. 23, Núm. 35, pp. 6403-6411

  2. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults

    The Lancet, Vol. 390, Núm. 10113, pp. 2627-2642

2016

  1. A century of trends in adult human height

    eLife, Vol. 5

  2. Evidence-based guidelines for the management of exocrine pancreatic insufficiency after pancreatic surgery

    Annals of Surgery, Vol. 264, Núm. 6, pp. 949-958

2013

  1. The gastric CB1 receptor modulates ghrelin production through the mTOR pathway to regulate food intake

    PLoS ONE, Vol. 8, Núm. 11

2010

  1. Peripheral endocannabinoid system-mediated actions of rimonabant on growth hormone secretion are ghrelin-dependent

    Journal of Neuroendocrinology, Vol. 22, Núm. 11, pp. 1127-1136

2006

  1. Central obestatin administration does not modify either spontaneous or ghrelin-induced food intake in rats

    Journal of Endocrinological Investigation, Vol. 29, Núm. 8

1988

  1. Human lymphoblastoic interferon for the treatment of chronic hepatitis B. A randomized controlled trial

    American Journal of Medicine, Vol. 85, Núm. 2 A, pp. 141-142